We have recently demonstrated that chronic treatment with the alpha-2A adrenoceptor (α2A-AR) agonist, guanfacine, downregulates the expression of α2A-AR in STZ-induced T1DM rats [27]. The gene discussed is ADRA2A; the disease is type 1 diabetes mellitus.